Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

squamous cell breast carcinoma News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

A case report and literature review highlight the multimodal imaging evaluation of early-stage metaplastic breast carcinoma with heterologous mesenchymal differentiation. This study contributes to the understanding of imaging techniques in rare breast cancer subtypes.

A case report highlights the long-term response to pembrolizumab in a patient with metastatic metaplastic breast carcinoma. This finding may inform future treatment strategies for this rare breast cancer subtype.

Not rare diseases news,news about your rare disease.

Earlier

A case report and literature review highlight the multimodal imaging evaluation of early-stage metaplastic breast carcinoma with heterologous mesenchymal differentiation. This study contributes to the understanding of imaging techniques in rare breast cancer subtypes.

A case report highlights the long-term response to pembrolizumab in a patient with metastatic metaplastic breast carcinoma. This finding may inform future treatment strategies for this rare breast cancer subtype.

Not rare diseases news,
news about your rare disease.